Doxycycline (Dox) can inhibit CALR protein expression, activate the JNK/p53 signaling pathway, and induce apoptosis in HMC3 cells, thereby achieving the therapeutic goal of treating brucellosis (Wang et al., 2021b). Here, TP53 is linked to brucellosis.